Alzheimer Disease: The Changing View: The Changing View

* Written in the words of those responsible for the widespread recognition of this neurodegenerative disease
* The authors are recognised as leaders in Alzheimer research and policy making

Audience: Healthcare professionals, academic clinicians in neurology and neuroscience, and educated persons interested in the disease.

Alzheimer disease has been completely redefined from a rare, early form of dementia to its current status as the fourth leading cause of death. The words of those responsible for this revolution are the heart of this book. Robert Katzman and Katherine Bick, leaders in Alzheimer research and policy making, interview the scientists, public health officials, government regulators, and activists who have helped unveil the mystery of this tragic disease. Alzheimer Disease: The Changing View chronicles the explosive increase in public awareness and funding, the establishment of diagnostic criteria, the development of therapeutic drugs, and the birth of the Alzheimer's Association.

Norman R. Relkin

The authors are imminently qualified to write on this subject...their first-hand knowledge of the period in question and of the individuals they interview enriches the book's content considerably.

Robert Katzman, M.D., a member of the Institute of Medicine of the National Academy of Sciences, is the recipient of numerous scientific awards. He has enjoyed a long career as a physician, neuroscientist, and policy maker, serving on the faculty at Albert Einstein University in New York and currently at the University of California, San Diego. His research has centered on the epidemiology of aging and Alzheimer disease, and his seminal editorial in 1976 sparked the NIH to hold the first conference on the subject. Dr. Katzman has been a catalyst in the formation of the Alzheimer's Association.

Katherine Bick, Ph.D., worked in academia for 20 years before joining the National Institutes of Health in 1976. At NIH she became a major figure in U.S. research and health care funding policy, serving as deputy director of the NINDS and later deputy director of NIH for extramural research. She has an avid interest in the history of Alzheimer disease and is one of the editors of the field's foremost text on the subject.